Comparative effectiveness of [(18) F]-fluorocholine PET-CT and pelvic MRI with diffusion-weighted imaging for staging in patients with high-risk prostate cancer.
about
Multiparametric magnetic resonance imaging for prostate cancer: A review and update for urologistsThe long-term outcomes of radical prostatectomy for very high-risk prostate cancer pT3b-T4 N0-1 on definitive histopathology.Effect of parallel radiofrequency transmission on arterial input function selection in dynamic contrast-enhanced 3 Tesla pelvic MRI.Imaging and evaluation of patients with high-risk prostate cancer.Current use of PSMA-PET in prostate cancer management.PET imaging for lymph node dissection in prostate cancer.Evaluation of tumor recurrences after radical prostatectomy using 18F-Choline PET/CT and 3T multiparametric MRI without endorectal coil: a single center experience.Circulating androgen receptor combined with 18F-fluorocholine PET/CT metabolic activity and outcome to androgen receptor signalling-directed therapies in castration-resistant prostate cancer.Comparison of 68Ga-PSMA-11 PET-CT with mpMRI for preoperative lymph node staging in patients with intermediate to high-risk prostate cancer.Lymph node imaging in initial staging of prostate cancer: An overview and update.The use of PET/CT in prostate cancer.Performance of 68Ga-PSMA PET/CT for Prostate Cancer Management at Initial Staging and Time of Biochemical Recurrence.Molecular imaging of prostate cancer.Molecular imaging using PSMA PET/CT versus multiparametric MRI for initial staging of prostate cancer: comparing apples with oranges?Clinical implications of PET/CT in prostate cancer management
P2860
Q26801576-48302366-223B-47F9-9BED-9C977D565736Q33609747-66FCDD1C-4CE6-4144-9638-603E95DE2302Q36359787-0787CF3E-603E-434B-866B-0DA1A790BB11Q38611187-EE579F3F-6BF6-4F5D-9F71-12D97690671BQ38744524-BAFDE396-CE34-4A87-B0A1-1FD06748D1AEQ38983526-81A6A715-3EAB-4A0A-9835-B51A534AE2BBQ39123279-541241ED-E290-4628-BD1F-D453F7644C65Q44453209-E37D4C09-F076-498D-9D0C-DFC3AA7FDCD9Q47097602-26401BD6-10C5-41F8-BA47-61EC03BC0458Q47157403-7BE98F6C-5770-44C8-9B96-CCE1CC9BF53CQ49919217-F6F9674C-0DA6-4CF2-B784-D98BBE554FDBQ50182743-18EC4A32-A06A-4EA9-A1D5-ABD3F1D7B10CQ52411549-9D517A58-15D2-48CC-AE03-F91D7FD2B7C9Q52983369-D8F0E55E-DCD7-4816-8000-226AEF85BCF7Q59137133-DE9A8194-2601-47CF-977C-03A709F98938
P2860
Comparative effectiveness of [(18) F]-fluorocholine PET-CT and pelvic MRI with diffusion-weighted imaging for staging in patients with high-risk prostate cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Comparative effectiveness of [
@nl
Comparative effectiveness of [ ...... ith high-risk prostate cancer.
@en
type
label
Comparative effectiveness of [
@nl
Comparative effectiveness of [ ...... ith high-risk prostate cancer.
@en
prefLabel
Comparative effectiveness of [
@nl
Comparative effectiveness of [ ...... ith high-risk prostate cancer.
@en
P2093
P2860
P356
P1433
P1476
Comparative effectiveness of [ ...... ith high-risk prostate cancer.
@en
P2093
Elif Hindie
Gerald Rigou
Gilles Pasticier
Henri De Clermont-Galleran
Jean-Baptiste Pinaquy
Nicolas Alberti
Philippe Fernandez
Yacoub Mokrane
P2860
P304
P356
10.1002/PROS.22921
P577
2014-11-12T00:00:00Z